More governments are giving their mark of approval to Samsung's ability to read and monitor your blood pressure and electrocardiogram. The company has announced that its Samsung Health Monitor app — where those tracking features can be found — will be available in 31 new countries.
The Galaxy Watch Active2 included hardware support for electrocardiogram (ECG) monitoring when it was released late last year, as did this year's Galaxy Watch3. The feature couldn't be enabled in the United States until it received FDA approval, leading to one of the watches' main selling points not (officially) working in America. At long last, Samsung has received the FDA's blessing, and ECG support is rolling out to both models. These features will also be coming to Galaxy Watches in the UK from February 22.
Samsung just unveiled the Galaxy Watch3 a couple days ago after plenty of leaksand speculation, but we're not done with the Watch3 news just yet. The Samsung Health app is currently being updated to support VO2max monitoring, and the FDA has approved its electrocardiogram (ECG) functionality for the US.
Samsung's forays into Wearable technology for the consumer market haven't been very groundbreaking, and a few never even touched down. Perhaps the secret was to aim higher than heart rate trackers and smartwatches. A small team at Samsung has been working in the company's Creativity Lab (a.k.a. C-Lab) developing a headset capable of observing brainwave patterns for signs of a stroke. Not only could the system help millions of people each year to prevent a crippling or fatal stroke, but the technology may have applications for monitoring the heart and brain for many other conditions.
The project began two years ago when the project lead, Se-hoon Lim, and 4 other engineers from the smartphone and washing machine divisions came together with the goal of an early warning system.